Editorial: Application of gene editing in neurodegenerative diseases, volume II

被引:2
|
作者
Qi, Fangfang [1 ,2 ]
Xu, Xingshun [3 ]
Guo, Xing [4 ]
Luo, Junhong [5 ]
Li, Yujing [6 ]
Yan, Sen [7 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Adv Med Technol Ctr, Zhongshan Sch Med,Dept Anat & Physiol,Guangdong Pr, Guangzhou, Peoples R China
[2] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[3] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China
[4] Nanjing Med Univ, Sch Basic Med Sci, Dept Neurobiol, Nanjing, Jiangsu, Peoples R China
[5] Jinan Univ, Sch Med, Dept Syst Biomed Sci, Guangzhou, Peoples R China
[6] Emory Univ, Dept Human Genet, Atlanta, GA USA
[7] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat, Guangdong Key Lab Nonhuman Primate Res, Guangzhou, Guangdong, Peoples R China
关键词
gene editing; neurodegenerative diseases; adeno-associated virus (AAV); animal model; CRISPR/Cas9;
D O I
10.3389/fnins.2023.1305302
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Editorial: Application of gene editing in pathology dissection of neurodegenerative diseases
    Yan, Sen
    Xu, Xingshun
    Qi, Fangfang
    Guo, Xing
    Luo, Junhong
    Li, Yujing
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [2] Editorial: Gene Silencing and Editing Strategies for Neurodegenerative Diseases
    Nobrega, Clevio
    Alves, Sandro
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [3] Editorial: The biochemistry of amyloids in neurodegenerative diseases, volume II
    Gomes, Claudio M.
    Hoyer, Wolfgang
    Luo, Jinghui
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [4] The Role of Gene Editing in Neurodegenerative Diseases
    Fan, Hueng-Chuen
    Chi, Ching-Shiang
    Lee, Yih-Jing
    Tsai, Jeng-Dau
    Lin, Shinn-Zong
    Harn, Horng-Jyh
    CELL TRANSPLANTATION, 2018, 27 (03) : 364 - 378
  • [5] Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases Volume II
    Wang, Fushun
    Xu, Shijun
    Pan, Fang
    Verkhratsky, Alex
    Huang, Jason H.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
    Kolli, Nivya
    Lu, Ming
    Maiti, Panchanan
    Rossignol, Julien
    Dunbar, Gary L.
    NEUROCHEMISTRY INTERNATIONAL, 2018, 112 : 187 - 196
  • [7] Editorial: The Biochemistry of Amyloids in Neurodegenerative Diseases, Volume I
    Gomes, Claudio M.
    Hoyer, Wolfgang
    Luo, Jinghui
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [8] Editing the Epigenome in Neurodegenerative Diseases
    A. S. Vetchinova
    E. Yu. Fedotova
    S. N. Illarioshkin
    Neurochemical Journal, 2021, 15 : 359 - 366
  • [9] Editing the Epigenome in Neurodegenerative Diseases
    Vetchinova, A. S.
    Fedotova, E. Yu.
    Illarioshkin, S. N.
    NEUROCHEMICAL JOURNAL, 2021, 15 (04) : 359 - 366
  • [10] Editorial: To Know or Not to Know: causes and evolution of lack of awareness of cognitive decline in neurodegenerative diseases, volume II
    Cacciamani, Federica
    Nielson, Kristy A.
    Hanseeuw, Bernard J.
    Gagliardi, Geoffroy P.
    Vannini, Patrizia
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 17